Bliss GVS Pharma Ltd (BLIS)

NSE
Currency in INR
152.32
-1.50(-0.98%)
Real-time Data·
BLIS Scorecard
Full Analysis
Trading at a low earnings multiple
Earnings results expected in 11 days
Fair Value
Day's Range
152.31155.70
52 wk Range
106.04185.50
Key Statistics
Edit
Bid/Ask
152.32 / 152.42
Prev. Close
153.82
Open
154.83
Day's Range
152.31-155.7
52 wk Range
106.04-185.5
Volume
103.05K
Average Volume (3m)
585.24K
1-Year Change
33.28%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLIS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Bliss GVS Pharma Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Bliss GVS Pharma Ltd Company Profile

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Employees
831
Market
India

Compare BLIS to Peers and Sector

Metrics to compare
BLIS
Peers
Sector
Relationship
P/E Ratio
19.2x30.0x−0.5x
PEG Ratio
1.630.300.00
Price/Book
1.5x3.3x2.6x
Price / LTM Sales
2.0x3.1x3.2x
Upside (Analyst Target)
-5.1%45.9%
Fair Value Upside
Unlock−2.6%7.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.02%
Dividend Yield
0.33%
Industry Median 0.75%
Annualised payout
0.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 12, 2025
EPS / Forecast
1.46 / --
Revenue / Forecast
2.34B / --
EPS Revisions
Last 90 days

BLIS Income Statement

People Also Watch

407.70
BAJE
-0.39%
1,724.90
CENA
+2.14%
65.74
RPOL
+1.43%
182.75
APLL
+1.64%
346.75
BPCL
+0.55%

FAQ

What Stock Exchange Does Bliss GVS Pharma Ltd Trade On?

Bliss GVS Pharma Ltd is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Bliss GVS Pharma Ltd?

The stock symbol for Bliss GVS Pharma Ltd is "BLIS."

What Is the Bliss GVS Pharma Ltd Market Cap?

As of today, Bliss GVS Pharma Ltd market cap is 16.13B.

What Is Bliss GVS Pharma Ltd's Earnings Per Share (TTM)?

The Bliss GVS Pharma Ltd EPS (TTM) is 8.02.

When Is the Next Bliss GVS Pharma Ltd Earnings Date?

Bliss GVS Pharma Ltd will release its next earnings report on 24 Jul 2025.

From a Technical Analysis Perspective, Is BLIS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Bliss GVS Pharma Ltd Stock Split?

Bliss GVS Pharma Ltd has split 1 times.

How Many Employees Does Bliss GVS Pharma Ltd Have?

Bliss GVS Pharma Ltd has 831 employees.

What is the current trading status of Bliss GVS Pharma Ltd (BLIS)?

As of 14 Jul 2025, Bliss GVS Pharma Ltd (BLIS) is trading at a price of 152.32, with a previous close of 153.82. The stock has fluctuated within a day range of 152.31 to 155.70, while its 52-week range spans from 106.04 to 185.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.